Logo image of ULY

URGENT.LY INC (ULY) Stock Fundamental Analysis

NASDAQ:ULY - Nasdaq - US9169312074 - Common Stock - Currency: USD

6.4  +0.77 (+13.68%)

Premarket: 6.69 +0.29 (+4.53%)

Fundamental Rating

2

Overall ULY gets a fundamental rating of 2 out of 10. We evaluated ULY against 282 industry peers in the Software industry. Both the profitability and financial health of ULY have multiple concerns. ULY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ULY has reported negative net income.
In the past year ULY has reported a negative cash flow from operations.
In the past 5 years ULY reported 4 times negative net income.
ULY had a negative operating cash flow in each of the past 5 years.
ULY Yearly Net Income VS EBIT VS OCF VS FCFULY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

ULY's Return On Assets of -78.60% is on the low side compared to the rest of the industry. ULY is outperformed by 88.30% of its industry peers.
Industry RankSector Rank
ROA -78.6%
ROE N/A
ROIC N/A
ROA(3y)-35.99%
ROA(5y)-37.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ULY Yearly ROA, ROE, ROICULY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 400 600

1.3 Margins

Looking at the Gross Margin, with a value of 22.52%, ULY is doing worse than 81.56% of the companies in the same industry.
In the last couple of years the Gross Margin of ULY has declined.
The Profit Margin and Operating Margin are not available for ULY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.99%
GM growth 5YN/A
ULY Yearly Profit, Operating, Gross MarginsULY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

2

2. Health

2.1 Basic Checks

ULY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ULY has less shares outstanding
Compared to 5 years ago, ULY has less shares outstanding
Compared to 1 year ago, ULY has a worse debt to assets ratio.
ULY Yearly Shares OutstandingULY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ULY Yearly Total Debt VS Total AssetsULY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -4.72, we must say that ULY is in the distress zone and has some risk of bankruptcy.
ULY has a worse Altman-Z score (-4.72) than 82.62% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.72
ROIC/WACCN/A
WACC9.86%
ULY Yearly LT Debt VS Equity VS FCFULY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 1.01 indicates that ULY should not have too much problems paying its short term obligations.
The Current ratio of ULY (1.01) is worse than 74.47% of its industry peers.
ULY has a Quick Ratio of 1.01. This is a normal value and indicates that ULY is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.01, ULY is not doing good in the industry: 73.40% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01
ULY Yearly Current Assets VS Current LiabilitesULY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

ULY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -147.29%.
The Revenue for ULY has decreased by -23.46% in the past year. This is quite bad
ULY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 305.71% yearly.
EPS 1Y (TTM)-147.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.21%
Revenue 1Y (TTM)-23.46%
Revenue growth 3Y336.36%
Revenue growth 5Y305.71%
Sales Q2Q%-22%

3.2 Future

ULY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.85% yearly.
Based on estimates for the next years, ULY will show a quite strong growth in Revenue. The Revenue will grow by 9.10% on average per year.
EPS Next Y75.75%
EPS Next 2Y38.56%
EPS Next 3Y26.85%
EPS Next 5YN/A
Revenue Next Year-10.47%
Revenue Next 2Y4.97%
Revenue Next 3Y9.1%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ULY Yearly Revenue VS EstimatesULY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ULY Yearly EPS VS EstimatesULY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -20 -40 -60 -80 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ULY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ULY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ULY Price Earnings VS Forward Price EarningsULY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ULY Per share dataULY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

ULY's earnings are expected to grow with 26.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.56%
EPS Next 3Y26.85%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ULY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

URGENT.LY INC

NASDAQ:ULY (6/30/2025, 8:00:01 PM)

Premarket: 6.69 +0.29 (+4.53%)

6.4

+0.77 (+13.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-11 2025-08-11
Inst Owners7.74%
Inst Owner Change-81.6%
Ins Owners4.28%
Ins Owner Change-3.86%
Market Cap7.94M
Analysts80
Price Target12.24 (91.25%)
Short Float %3.6%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-93.81%
Min EPS beat(2)-121.92%
Max EPS beat(2)-65.7%
EPS beat(4)0
Avg EPS beat(4)-51.61%
Min EPS beat(4)-121.92%
Max EPS beat(4)-3.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-0.44%
Max Revenue beat(2)0.68%
Revenue beat(4)1
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)0.68%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)24.54%
EPS NQ rev (3m)24.54%
EPS NY rev (1m)-8.58%
EPS NY rev (3m)-8.58%
Revenue NQ rev (1m)-5.49%
Revenue NQ rev (3m)-5.49%
Revenue NY rev (1m)-7.42%
Revenue NY rev (3m)-14.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-32.54
EYN/A
EPS(NY)-2.91
Fwd EYN/A
FCF(TTM)-26.68
FCFYN/A
OCF(TTM)-21.16
OCFYN/A
SpS108.13
BVpS-29.1
TBVpS-36.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -78.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.52%
FCFM N/A
ROA(3y)-35.99%
ROA(5y)-37.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.99%
GM growth 5YN/A
F-Score4
Asset Turnover2.89
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 166.36%
Cap/Sales 5.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z -4.72
F-Score4
WACC9.86%
ROIC/WACCN/A
Cap/Depr(3y)63.32%
Cap/Depr(5y)101.16%
Cap/Sales(3y)2.81%
Cap/Sales(5y)25.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-147.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.21%
EPS Next Y75.75%
EPS Next 2Y38.56%
EPS Next 3Y26.85%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.46%
Revenue growth 3Y336.36%
Revenue growth 5Y305.71%
Sales Q2Q%-22%
Revenue Next Year-10.47%
Revenue Next 2Y4.97%
Revenue Next 3Y9.1%
Revenue Next 5YN/A
EBIT growth 1Y51.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year94.95%
EBIT Next 3Y34.93%
EBIT Next 5YN/A
FCF growth 1Y18.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.78%
OCF growth 3YN/A
OCF growth 5YN/A